Chair, Ferronova

Dr John Parker

Roles

Role	Organisation	Sources
Chair	Ferronova	SmartCompany, Startup Daily
Chair (former)	FerronovaPrecision cancer treatment technology	ferronova.com.au

Coverage

Stories naming Dr John Parker. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

2 deals

‘No tumour will go undetected’: Ferronova lands $11 million for its cancer hunting nanotechnology

Adelaide biotech Ferronova raised $11 million for its cancer-detection nanotechnology, with Renew Pharmaceuticals and a government CRC contributing, following an earlier $4.6 million Series A in 2020.

SmartCompany Mon 23 Jan 2023 Ferronova Renew Pharmaceuticals Royal Adelaide Hospital Artesian VC Cooperative Research Centre Previously existing shareholders Uniseed Dr John Parker Stewart Bartlett

Also SmartCompany

2 deals

South Australian biotech startup Ferronova banks $11 million to tackle cancer treatment

Adelaide cancer-focused biotech Ferronova has secured fresh backing: an investor round led by Irish strategic partner Renew Pharmaceuticals plus a federal research grant, to speed clinical trials in stomach and brain cancers.

Startup Daily Mon 23 Jan 2023 Ferronova Macquarie Bank PAN Ventures Powerhouse Ventures Royal Adelaide Hospital South Australian Venture Capital Fund The University of Sydney University of South Australia University of Wellington Artesian VC Renew Pharmaceuticals the federal government Uniseed Allan Moss Declan Cassells Dr John Parker Stewart Bartlett

Also SmartCompany·SmartCompany·SmartCompany·Startup Daily·Business News Australia·Startup Daily

2 deals

Ferronova secures A$11 million to advance nanotech image-guided cancer therapy

Adelaide biotech Ferronova announced an A$11 million package: an A$8 million round led by Ireland's Renew Pharmaceuticals plus an A$3 million government CRC-P grant, with existing shareholders Uniseed and Artesian also participating.

Something wrong? Tell us